Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2014
04/17/2014WO2014056025A1 Improved process for purifying lactoferrin from milk and products thereof
04/17/2014WO2014033540A3 Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof
04/17/2014WO2014025771A3 Methods and compositions for inactivating enveloped viruses
04/17/2014WO2014024173A9 Recombinant human fibroblast growth factor-1 as a novel therapeutic for ischemic diseases and methods thereof
04/17/2014WO2014009738A3 Treatment of muscular dystrophy
04/17/2014WO2014005103A3 Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture
04/17/2014WO2013130102A3 Dual ox40 agonist/il-2 cancer therapy methods
04/17/2014WO2013101014A3 High pressure treatment of aggregated interferons
04/17/2014WO2013059610A9 Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
04/17/2014WO2013029011A8 Methods and compositions comprising a c-terminal bax peptide
04/17/2014WO2013021212A3 Modified osteopontin peptides having an inactivated rgd domain and uses thereof
04/17/2014WO2012173781A3 Methods of treating glucose metabolism disorders
04/17/2014WO2012119103A3 Compositions and methods for mobilization of stem cells
04/17/2014WO2012112626A3 Compositions, devices and methods of use thereof for the treatment of cancers
04/17/2014WO2012109469A3 Methods of treating alzheimer's disease with apo a-1 milano
04/17/2014WO2012106725A3 Methods and compositions for treating occular disorders
04/17/2014WO2012078936A3 Methods to produce a purified peptide chain fraction
04/17/2014WO2012074559A3 Treatment of non-proliferative cystic disease
04/17/2014US20140107391 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
04/17/2014US20140107227 Mucoadhesive drug delivery devices and methods of making and using thereof
04/17/2014US20140107181 Methods and means for treatment of osteoarthritis
04/17/2014US20140107116 Benzothiazole derivatives for the treatment of diabetes
04/17/2014US20140107042 Compositions, methods and uses for radioprotectants
04/17/2014US20140107041 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
04/17/2014US20140107038 Method for administering omega-conopeptide
04/17/2014US20140107037 Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
04/17/2014US20140107036 Production and Delivery of a Stable Collagen
04/17/2014US20140107035 Methods of treating fibrosing diseases by induction of immune tolerance
04/17/2014US20140107033 Methods for prevention and treatment of acute renal injury
04/17/2014US20140107032 Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events
04/17/2014US20140107030 Polypeptide compounds for inhibiting angiogenesis and tumor growth
04/17/2014US20140107029 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
04/17/2014US20140107026 Bone morphogenetic proteins for the treatment of insulin resistance
04/17/2014US20140107025 Ocular drug delivery system
04/17/2014US20140107024 Treatment of Type 2 Diabetes With FTY720
04/17/2014US20140107021 Glucagon antagonist-gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
04/17/2014US20140107020 Fibronectin based scaffold domain proteins that bind to myostatin
04/17/2014US20140107017 Methods for Treating HCV
04/17/2014US20140107016 Methods for Treating HCV
04/17/2014US20140107014 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
04/17/2014US20140106450 Compositions and Methods for Inhibiting Expression of a Target Gene
04/17/2014US20140106341 Stabilized bioactive peptides and methods of identification, synthesis, and use
04/17/2014US20140106004 Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence
04/17/2014US20140105993 Modified-release microparticles based on amphiphilic copolymer and on active principle(s) and pharmaceutical formulations comprising them
04/17/2014US20140105990 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
04/17/2014US20140105978 Silk microspheres for encapsulation and controlled release
04/17/2014US20140105960 Hydrogels for tissue regeneration
04/17/2014US20140105951 Sericin extracted fabrics
04/17/2014US20140105939 Methods and compositions for modulating myofibroblast activities
04/17/2014US20140105911 Method Of Treatment Of Vascular Complications
04/17/2014US20140105898 Apoptosis-inducing molecules and uses therefor
04/17/2014US20140105896 Fibronectin based scaffold domain proteins that bind to myostatin
04/17/2014US20140105884 Material and method for treating internal cavities
04/17/2014US20140105883 Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds
04/17/2014US20140105882 Therapeutic composition with a botulinum neurotoxin
04/17/2014US20140105880 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
04/17/2014US20140105868 Method for treating vascular-related disease
04/17/2014US20140105860 Engineered antibody-tnfsf member ligand fusion molecules
04/17/2014US20140105859 Modulators of pharmacokinetic properties of therapeutics
04/17/2014US20140105858 Ifn-beta compositions, preparation methods and uses thereof
04/17/2014US20140105857 Compositions and methods for enhancing active agent absorption
04/17/2014US20140105856 System and Method for Collagen Isolation
04/17/2014US20140105853 Prostate cancer vaccine
04/17/2014US20140105824 Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
04/17/2014US20140105818 Novel Vesicles and Nanostructures from Recombinant Proteins
04/17/2014DE102013220603A1 Mittel zur Steigerung einer Antigenduldung im Organismus verbunden mit einer Entzündungshemmung Means to increase the tolerance associated antigen in the body and inhibition of inflammation
04/16/2014EP2719704A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
04/16/2014EP2719393A1 Freeze-dried preparation containing high-purity pth and method for producing same
04/16/2014EP2719392A1 Suppression of neuroendocrine diseases
04/16/2014EP2719290A1 A microencapsulated amino acid composition and method of manufacturing microencapsulated amino acid composition
04/16/2014EP2718728A1 Targets and agents for the treatment of impaired bone fracture healing
04/16/2014EP2718457A1 Engineered antibody-tnfsf member ligand fusion molecules
04/16/2014EP2718441A1 Multiple interferon and virus response element cell-based fluorescence system
04/16/2014EP2718328A1 Compositions and methods for increasing serum half-life
04/16/2014EP2718318A2 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
04/16/2014EP2718317A1 Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
04/16/2014EP2718308A1 Pseudomonas exotoxin a with less immunogenic t cell and/or b cell epitopes
04/16/2014EP2718307A1 Beta - hairpin peptidomimetics as cxc4 antagonists
04/16/2014EP2717965A1 Use of epsilon-poly-l-lysine for increasing the bioavailability of antimicrobial peptides in the human skin
04/16/2014EP2717925A1 Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof
04/16/2014EP2717921A2 Retinoid-liposomes for enhancing modulation of hsp47 expression
04/16/2014EP2717918A2 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
04/16/2014EP2717908A1 Cetp fragments
04/16/2014EP2717907A1 Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis
04/16/2014EP2717906A2 The use of alkaline phosphatase for preserving renal function
04/16/2014EP2717905A1 Treatment of coagulation disease by administration of recombinant vwf
04/16/2014EP2717904A1 Pharmaceutical preparation comprising recombinant fsh
04/16/2014EP2717903A2 Methods of treatment for retinal diseases
04/16/2014EP2717902A1 Use of modified vasoactive intestinal peptides in the treatment of hypertension
04/16/2014EP2717901A2 He4 based therapy for malignant disease
04/16/2014EP2717900A1 Scaffold-kinase interaction blockades and uses thereof in treating cancer
04/16/2014EP2717899A2 Shk-based pharmaceutical compositions and methods of manufacturing and using the same
04/16/2014EP2717898A2 Pro-coagulant compounds and methods of use thereof
04/16/2014EP2717897A2 Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
04/16/2014EP2717896A1 Therapeutic agents for regulating serum phosphorus
04/16/2014EP2717895A1 Therapeutic compounds for immunomodulation
04/16/2014EP2717894A1 Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
04/16/2014EP2717893A1 Lipid nanoparticle compositions and methods for mrna delivery
04/16/2014EP2717854A1 Treatment of cancers and metastases with suspensions of cilengitide in carrier
04/16/2014CN103732743A Mphosph1 peptides and vaccines including the same
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 3163